Ex Officio Member
Director, Office of In Vitro Diagnostics and Radiological Health
Center for Devices and Radiological Health
Office of Product Evaluation and Quality
Food and Drug Administration
Silver Spring, MD
Dr. Stenzel joined the FDA in July 2018 and has an extensive background, spanning more than 20 years, in executive leadership, innovation, companion diagnostics, research and development, FDA regulations, and clinical laboratory operations. As the Director of the FDA’s Office of In Vitro Diagnostics and Radiological Health, Dr. Stenzel advises Center leadership on all regulatory (premarket and postmarket) in vitro diagnostics, radiological medical device, and radiation-emitting product issues that have an impact on Center and Agency level decisions, policy development, nationwide program execution, and short- and long-range program goals and objectives in addition to providing executive leadership and scientific direction to staff.